AUPH · ISSUER CIK 1600620
Aurinia Pharmaceuticals Inc.
Between Aug 1, 2026 and Oct 29, 2026, 1 Aurinia Pharmaceuticals Inc. insiders reported $0.00 of open-market purchases and $546K of sales on SEC Form 4.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 2 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$546KInsider selling
−$546KNet open-market
Sep 11, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 202616:26 | Sep 10, 2026 | AUPH | Chief Legal Officer | S · Sell | $15.95 | −11,939 | 588,848 | -2% | −$190K | ||
| Aug 25, 202621:29 | Aug 21, 2026 | AUPH | Chief Legal Officer | S · Sell | $16.97 | −20,975 | 600,787 | -3% | −$356K |